Corporació Sanitària Parc Taulí
Sabadell, Barcelona, 08208, Spain
NCT Number: NCT04610086
A cross sectional multicenter study (3 centers) to know the participation in decision making and the experience and satisfaction of participants with a positive immunological fecal test (FIT) result in relation to the screening process and the diagnostic-therapeutic process of cancer.
We will include 850 participants with a positive FIT result and will classify them by their final diagnosis (false positives of FIT; polyps; colo-rectal cancer).
Outcomes of interest will be measured by auto administered questionnaires:
collaboRATE, SDM-Q-9, OUT-PATSAT35 and a satisfaction questionnaire developed in a previous study.
Looking for future studies?
Notify Me49 year–69 year
All sexes
Observational
Sabadell, Barcelona, 08208, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months
Perception of participants of shared decision making
Time frame: 2 months
Satisfacion with the screening process
Time frame: at 6 months
Satisfaction with the diagnostic and treatment processess of cancer
Time frame: at 6 months
Patient perception about participation in decision making during the diagnostic and treatment processess of cancer
Corporacion Parc Tauli
Other
Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Context of the Colorectal Cancer Screening Program. The CyDESA Study.
Acronym: CyDESA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01695863
Behavior, Colonic Diseases
Chicago, Illinois, United States
View Trial DetailsNCT03421912
Behavior, Bronchial Neoplasms
Lyon, Rhône, France
View Trial DetailsNCT03677050
Behavior, Colonic Diseases
Maastricht, Limburg, Netherlands
View Trial DetailsNCT02428907
Behavior, Colonic Diseases
Aalborg, Denmark
View Trial Details